🇩🇪 Germany · EU Public Tender
First-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (Kopie)
🏛️ BiconY Therapeutics GmbH · 📍 Leipzig
—
Estimated value
16 December 2024
Deadline
| Contract type | Services |
| CPV | 85145000 |
| Deadline | 16 December 2024 |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.